Biogen Idec (Nasdaq: BIIB) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that they have entered into an exclusive, worldwide ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE